期刊文献+

优质护理干预应用于急性ST段抬高型心肌梗死患者早期溶栓治疗中的效果 被引量:1

Effect of high quality nursing intervention on early thrombolytic therapy in patients with acute ST-segment elevation myocardial infarction
下载PDF
导出
摘要 目的探究急性ST段抬高型心肌梗死(STEMI)早期溶栓治疗中优质护理干预的临床效果。方法回顾性分析接受早期溶栓治疗的126例患者临床资料,根据护理方式分为优质组(66例,优质护理)与常规组(60例,常规护理),比较两组的临床效果。结果优质组心肌功能恢复时间、住院时间短于常规组(P<0.05),优质组住院期间STEMI再发率低于常规组(P<0.05),优质组患者护理满意度高于常规组(P<0.05),优质组并发症总发生率低于比常规组(P<0.05)。结论优质护理干预可缩短STEMI患者心肌功能恢复时间、住院时间,降低STEMI再发率,提升溶栓治疗期间患者护理满意度,减少并发症发生。 Objective To investigate the clinical effect of high-quality nursing intervention on early thrombolytic therapy in patients with acute ST-elevation myocardial infarction(STEMI). Methods The clinical data of 126 patients undergoing early thrombolysis were retrospectively analyzed. According to the nursing methods, the patients were divided into high quality group(66 cases, high quality nursing) and routine group(60 cases, routine nursing). The clinical effects of the two groups were compared. Results The recovery time of myocardial function and hospital stay of the high quality group were shorter than those of the routine group(P〈0.05). The recurrence rate of STEMI during hospitalization of the high quality group was lower than that of the routine group(P〈0.05), and the nursing satisfaction of the high quality group was higher than that of the routine group(P〈0.05). The total incidence of complications of the high quality group was lower than that of the routine group(P〈0.05). Conclusion High-quality nursing intervention can shorten the recovery time of myocardial function, hospital stay,reduce the recurrence rate of STEMI, improve patients' satisfaction and reduce complications during thrombolytic therapy.
作者 余丽丽 代丽丽 YU Li-li;DAI Li-li(Cardiology Department,the Hospital of Sanyuan County,Xianyang 713800,China)
出处 《临床医学研究与实践》 2018年第17期195-196,共2页 Clinical Research and Practice
关键词 优质护理 心肌梗死 早期溶栓 high-quality nursing myocardial infarction early thrombolysis
  • 相关文献

参考文献7

二级参考文献56

  • 1急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1321
  • 2洪涛.冠状动脉TIMI血流分级[J].中国介入心脏病学杂志,2003,11(3):154.
  • 3Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 pa- tients. Fibrinolytic Therapy Trialists' (TI') Collaborative Group [J]. Lancet, 1994,343(8893):311-322.
  • 4Kastrati A, Neumann FJ, Schulz S, et al. Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction [J] N Engl J Med,2011,365( 21):1980-1989.
  • 5Stone GW, Witzenbichler B, Guagliumi G, et al. Heparin plus aglycoprotein 11 b/m a inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction ( HORIZONS- AMI):final 3- year results from a muhicentre randomised controlled trial [J] Lancet, 2011, 377( 9784):2193-2204.
  • 6Krumho|z HM, Anderson JL, Brooks NH, et al. ACC/AHA clini- cal performance measures for adults with ST-elevation and non- STelevation myocardial infarction: a report of the ACC/AHA Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction) [J]. Circulation, 2006, 113 (5): 732- 761.
  • 7Razakjr OA, Tan HC, Yip WL, et al. Predictors of bleeding com- plications and thrombocytopenia with the use of abciximab during pereutaneous coronary intervention [J]. J Interv Cardiol, 2005, 18 ( 1 ) : 33-37.
  • 8Kastrati A, Neumann F J, Schulz S, et al. Abeiximab and heparin versus bivalirudin for non-ST-elevation myocardial in-farction [J]. N Engl J Med,2011,365(21 ):1980-1989.
  • 9Stone GW, Witzenbiehler B, Guagliumi G, et al. Heparin plus a glyeoprotein Ilb/IIIa inhibitor versus bivalirudin monotherapy and paelitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS- AMI): final 3- year results from a multieentre, randomised controlled trial [J ]. Lancet, 2011, 377 ( 9784 ) :2193-2204.
  • 10Mehran R, Lansky A J, Witzenbichler B, et al. Bivalirudin in pa- tients undergoing primary angioplasty for acute myocardial in- farction (HORIZONS- AMI): 1- year results of a randomised controlled trial [ J ]. Lancet, 2009,374 (9696): 1149-1159.

共引文献5071

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部